Board & advisory inquiry

Let's talk about a board or advisory conversation.

Whether it's a board seat, scientific or strategic advisory role, investor diligence, or association leadership — share the organization, the stage, the timing, and what you're hoping to discuss.

Every inquiry is reviewed personally. Board, advisory, and speaking commitments are taken on through Dauntless eClinical Strategies, alongside my full-time role.

Not open for standalone consulting engagements.

Inquiry type

Board & advisory

Signature topics

What I speak about.

Each topic is a named talk, booked as a keynote, panel, or private executive session.

Decentralized Clinical Trials — Beyond the Hype

Twelve years building the platforms behind DCTs — what's worked, what didn't, and what the next chapter actually looks like for sponsors.

Building the Modern eClinical Stack

How sponsors connect EDC, eCOA, eSource, ePRO, sensors, and RWD into something operationally real — and regulator-defensible.

AI in Clinical Development

Where AI is genuinely changing trial operations — and where it's still a slide deck looking for a clinical workflow.

Patient-Centric Trials in Practice

What patient centricity means once it has to survive a CRO, an EDC, an IRB, and a regulator.